>>Signaling Pathways>> Neuroscience>> 5-HT Receptor>>Tertatolol ((±)-Tertatolol)

Tertatolol ((±)-Tertatolol) (Synonyms: (±)?-?Tertatolol; Racemic Tertatolol; dl-?Tertatolol)

Catalog No.GC32637

Tertatolol((±)-Tertatolol)은 베타-아드레날린 수용체 및 5-HT 수용체의 강력한 길항제이며 독특한 신장 혈관 확장 효과가 있습니다.

Products are for research use only. Not for human use. We do not sell to patients.

Tertatolol ((±)-Tertatolol) Chemical Structure

Cas No.: 83688-84-0

Size 가격 재고 수량
1mg
US$1,176.00
재고 있음
5mg
US$2,354.00
재고 있음
10mg
US$3,998.00
재고 있음
20mg
US$7,060.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com


고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tertatolol is a potent antagonist of beta-adrenoceptor and 5-HT receptor, with unique renal vasodilatatory effects.

In serum-free media, tertatolol does not significantly alter the incorporation of 3H-thymidine after 28 h of incubation in human mesangial cell (HMC). In the presence of 1% serum, tertatolol significantly reduces 3H-thymidine incorporation. Tertatolol also inhibits 3H incorporation when PDGF and thrombin are used as the stimulus. Tertatolol inhibits the reduction in planar surface area of HMC induced by angiotensin II. The inhibitory effect of tertatolol on HMC proliferation is also potentiated by ritanserin and MDL 72222, 5HT2 and 5HT3 antagonists, respectively[1].

[1]. Shultz P, et al. Tertatolol: a beta-blocker with unique effects on human glomerular cell function. Cardiology. 1993;83 Suppl 1:51-6.

리뷰

Review for Tertatolol ((±)-Tertatolol)

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tertatolol ((±)-Tertatolol)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.